HoefnagelCADelpratCCZaninDVan Der SchootJB. New radionuclide tracers for the diagnosis and therapy of medullary thyroid carcinoma. Clin Nucl Med1988; 13: 159–65.
2.
ClarkeSEMLazarusCRWraightPSampsonCMaiseyMN. Pentavalent [99mTc]DMSA, [131I]MIBG, and [99mTc]MDP — an evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid. J Nucl Med1988; 29: 33–8.
3.
GuerraUPPizzocaroCTerziA. New tracers for the imaging of the medullary thyroid carcinoma. Nucl Med Commun1989; 10: 285–95.
4.
OhtaHYamomotoKEndoKOhtaH. A new imaging agent for medullary carcinoma of the thyroid. J Nucl Med1984; 25: 323–5.
5.
MiyauchiAEndoKOhtaH. 99mTc(V)-dimercaptosuccinic acid scintigraphy for medullary thyroid carcinoma. World J Surg1986; 10: 640–5.
6.
RamamoorthyNShetyeSVPandeyPM. Preparation and evaluation of 99mTc(V)-DMSA complex: studies in medullary carcinoma of the thyroid. Eur J Nucl Med1987; 12: 623–8.
7.
ClarkeSEMLazarusCMistryRMaiseyMN. The role of technetium-99m pentavalent DMSA in the management of patients with medullary carcinoma of the thyroid. Br J Radiol1987; 60: 1089–92.
8.
UdelsmanRMojiminiyiOASoperNDW. Medullary carcinoma of the thyroid: management of persistent hypercalcitonemia utilizing [99mTc](v) dimercaptosuccinic acid scintigraphy. Br J Surg1989; 76: 1278–81.
9.
MojiminiyiOAUdelsmanRSoperNDWShepstoneBJDudleyNE. Pentavalent Tc-99m DMSA scintigraphy. Prospective evaluation of its role in the management of patients with medullary carcinoma of the thyroid. Clin Nucl Med1991; 16: 259–62.
10.
GuerraUPizzocaroCPizzocaroC. The use of 99mTc(V)DMSA as imaging for the medullary thyroid carcinoma (MCT). J Nucl Med Allied Sci1988; 32: 242–7.
